Cell and Gene Therapy Market by Therapy Type (Cell Therapy, Gene Therapy), Indication (Cardiovascular Disease, Oncology Disorder, Genetic Disorder, Infectious Disease, Neurological Disorder, and Others), Delivery Mode (In-Vivo, Ex-Vivo), End User (Hospitals, Cancer Care Centers, Pharmaceutical & Biotechnology Companies, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112025A6964

Buy Now

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Global Cell and Gene Therapy Market - Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Global Cell and Gene Therapy Market Landscape
5.1 Historical and Current Market Trends (2018-2023)
5.2 Market Forecast (2024-2032)

6 Global Cell and Gene Therapy Market - Breakup by Therapy Type
6.1 Cell Therapy
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2018-2023)
6.1.3 Market Segmentation
6.1.3.1 Stem Cell
6.1.3.1.1 Pluripotent Stem Cell
6.1.3.1.2 Cancer Stem Cell
6.1.3.1.3 Adult Stem Cell
6.1.3.2 Non-Stem Cell
6.1.3.2.1 T-Cell
6.1.3.2.2 Natural Killer Cell
6.1.3.2.3 Others
6.1.4 Market Forecast (2024-2032)
6.2 Gene Therapy
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2018-2023)
6.2.3 Market Segmentation
6.2.4 Market Forecast (2024-2032)
6.3 Attractive Investment Proposition by Therapy Type

7 Global Cell and Gene Therapy Market - Breakup by Indication
7.1 Cardiovascular Disease
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2018-2023)
7.1.3 Market Segmentation
7.1.4 Market Forecast (2024-2032)
7.2 Oncology Disorder
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2018-2023)
7.2.3 Market Segmentation
7.2.4 Market Forecast (2024-2032)
7.3 Genetic Disorder
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2018-2023)
7.3.3 Market Segmentation
7.3.4 Market Forecast (2024-2032)
7.4 Infectious Disease
7.4.1 Overview
7.4.2 Historical and Current Market Trends (2018-2023)
7.4.3 Market Segmentation
7.4.4 Market Forecast (2024-2032)
7.5 Neurological Disorder
7.5.1 Overview
7.5.2 Historical and Current Market Trends (2018-2023)
7.5.3 Market Segmentation
7.5.4 Market Forecast (2024-2032)
7.6 Others
7.6.1 Historical and Current Market Trends (2018-2023)
7.6.2 Market Forecast (2024-2032)
7.7 Attractive Investment Proposition by Indication

8 Global Cell and Gene Therapy Market - Breakup by Delivery Mode
8.1 In-Vivo
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2018-2023)
8.1.3 Market Segmentation
8.1.4 Market Forecast (2024-2032)
8.2 Ex-Vivo
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2018-2023)
8.2.3 Market Segmentation
8.2.4 Market Forecast (2024-2032)
8.3 Attractive Investment Proposition by Delivery Mode

9 Global Cell and Gene Therapy Market - Breakup by End User
9.1 Hospitals
9.1.1 Overview
9.1.2 Historical and Current Market Trends (2018-2023)
9.1.3 Market Segmentation
9.1.4 Market Forecast (2024-2032)
9.2 Cancer Care Centers
9.2.1 Overview
9.2.2 Historical and Current Market Trends (2018-2023)
9.2.3 Market Segmentation
9.2.4 Market Forecast (2024-2032)
9.3 Pharmaceutical & Biotechnology Companies
9.3.1 Overview
9.3.2 Historical and Current Market Trends (2018-2023)
9.3.3 Market Segmentation
9.3.4 Market Forecast (2024-2032)
9.4 Others
9.4.1 Overview
9.4.2 Historical and Current Market Trends (2018-2023)
9.4.3 Market Segmentation
9.4.4 Market Forecast (2024-2032)
9.5 Attractive Investment Proposition by End User

10 Global Cell and Gene Therapy Market – Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Drivers
10.1.1.2 Historical and Current Market Trends (2018-2023)
10.1.1.3 Market Breakup by Therapy Type
10.1.1.4 Market Breakup by Indication
10.1.1.5 Market Breakup by Delivery Mode
10.1.1.6 Market Breakup by End User
10.1.1.7 Key Players
10.1.1.8 Market Forecast (2024-2032)
10.1.2 Canada
10.1.2.1 Market Drivers
10.1.2.2 Historical and Current Market Trends (2018-2023)
10.1.2.3 Market Breakup by Therapy Type
10.1.2.4 Market Breakup by Indication
10.1.2.5 Market Breakup by Delivery Mode
10.1.2.6 Market Breakup by End User
10.1.2.7 Key Players
10.1.2.8 Market Forecast (2024-2032)
10.2 Europe
10.2.1 Germany
10.2.1.1 Market Drivers
10.2.1.2 Historical and Current Market Trends (2018-2023)
10.2.1.3 Market Breakup by Therapy Type
10.2.1.4 Market Breakup by Indication
10.2.1.5 Market Breakup by Delivery Mode
10.2.1.6 Market Breakup by End User
10.2.1.7 Key Players
10.2.1.8 Market Forecast (2024-2032)
10.2.2 France
10.2.2.1 Market Drivers
10.2.2.2 Historical and Current Market Trends (2018-2023)
10.2.2.3 Market Breakup by Therapy Type
10.2.2.4 Market Breakup by Indication
10.2.2.5 Market Breakup by Delivery Mode
10.2.2.6 Market Breakup by End User
10.2.2.7 Key Players
10.2.2.8 Market Forecast (2024-2032)
10.2.3 United Kingdom
10.2.3.1 Market Drivers
10.2.3.2 Historical and Current Market Trends (2018-2023)
10.2.3.3 Market Breakup by Therapy Type
10.2.3.4 Market Breakup by Indication
10.2.3.5 Market Breakup by Delivery Mode
10.2.3.6 Market Breakup by End User
10.2.3.7 Key Players
10.2.3.8 Market Forecast (2024-2032)
10.2.4 Italy
10.2.4.1 Market Drivers
10.2.4.2 Historical and Current Market Trends (2018-2023)
10.2.4.3 Market Breakup by Therapy Type
10.2.4.4 Market Breakup by Indication
10.2.4.5 Market Breakup by Delivery Mode
10.2.4.6 Market Breakup by End User
10.2.4.7 Key Players
10.2.4.8 Market Forecast (2024-2032)
10.2.5 Spain
10.2.5.1 Market Drivers
10.2.5.2 Historical and Current Market Trends (2018-2023)
10.2.5.3 Market Breakup by Therapy Type
10.2.5.4 Market Breakup by Indication
10.2.5.5 Market Breakup by Delivery Mode
10.2.5.6 Market Breakup by End User
10.2.5.7 Key Players
10.2.5.8 Market Forecast (2024-2032)
10.2.6 Others
10.2.6.1 Historical and Current Market Trends (2018-2023)
10.2.6.2 Market Forecast (2024-2032)
10.3 Asia Pacific
10.3.1 China
10.3.1.1 Market Drivers
10.3.1.2 Historical and Current Market Trends (2018-2023)
10.3.1.3 Market Breakup by Therapy Type
10.3.1.4 Market Breakup by Indication
10.3.1.5 Market Breakup by Delivery Mode
10.3.1.6 Market Breakup by End User
10.3.1.7 Key Players
10.3.1.8 Market Forecast (2024-2032)
10.3.2 Japan
10.3.2.1 Market Drivers
10.3.2.2 Historical and Current Market Trends (2018-2023)
10.3.2.3 Market Breakup by Therapy Type
10.3.2.4 Market Breakup by Indication
10.3.2.5 Market Breakup by Delivery Mode
10.3.2.6 Market Breakup by End User
10.3.2.7 Key Players
10.3.2.8 Market Forecast (2024-2032)
10.3.3 India
10.3.3.1 Market Drivers
10.3.3.2 Historical and Current Market Trends (2018-2023)
10.3.3.3 Market Breakup by Therapy Type
10.3.3.4 Market Breakup by Indication
10.3.3.5 Market Breakup by Delivery Mode
10.3.3.6 Market Breakup by End User
10.3.3.7 Key Players
10.3.3.8 Market Forecast (2024-2032)
10.3.4 South Korea
10.3.4.1 Market Drivers
10.3.4.2 Historical and Current Market Trends (2018-2023)
10.3.4.3 Market Breakup by Therapy Type
10.3.4.4 Market Breakup by Indication
10.3.4.5 Market Breakup by Delivery Mode
10.3.4.6 Market Breakup by End User
10.3.4.7 Key Players
10.3.4.8 Market Forecast (2024-2032)
10.3.5 Australia
10.3.5.1 Market Drivers
10.3.5.2 Historical and Current Market Trends (2018-2023)
10.3.5.3 Market Breakup by Therapy Type
10.3.5.4 Market Breakup by Indication
10.3.5.5 Market Breakup by Delivery Mode
10.3.5.6 Market Breakup by End User
10.3.5.7 Key Players
10.3.5.8 Market Forecast (2024-2032)
10.3.6 Indonesia
10.3.6.1 Market Drivers
10.3.6.2 Historical and Current Market Trends (2018-2023)
10.3.6.3 Market Breakup by Therapy Type
10.3.6.4 Market Breakup by Indication
10.3.6.5 Market Breakup by Delivery Mode
10.3.6.6 Market Breakup by End User
10.3.6.7 Key Players
10.3.6.8 Market Forecast (2024-2032)
10.3.7 Others
10.3.7.1 Historical and Current Market Trends (2018-2023)
10.3.7.2 Market Forecast (2024-2032)
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Drivers
10.4.1.2 Historical and Current Market Trends (2018-2023)
10.4.1.3 Market Breakup by Therapy Type
10.4.1.4 Market Breakup by Indication
10.4.1.5 Market Breakup by Delivery Mode
10.4.1.6 Market Breakup by End User
10.4.1.7 Key Players
10.4.1.8 Market Forecast (2024-2032)
10.4.2 Mexico
10.4.2.1 Market Drivers
10.4.2.2 Historical and Current Market Trends (2018-2023)
10.4.2.3 Market Breakup by Therapy Type
10.4.2.4 Market Breakup by Indication
10.4.2.5 Market Breakup by Delivery Mode
10.4.2.6 Market Breakup by End User
10.4.2.7 Key Players
10.4.2.8 Market Forecast (2024-2032)
10.4.3 Others
10.4.3.1 Historical and Current Market Trends (2018-2023)
10.4.3.2 Market Forecast (2024-2032)
10.5 Middle East and Africa
10.5.1.1 Market Drivers
10.5.1.2 Historical and Current Market Trends (2018-2023)
10.5.1.3 Market Breakup by Therapy Type
10.5.1.4 Market Breakup by Indication
10.5.1.5 Market Breakup by Delivery Mode
10.5.1.6 Market Breakup by End User
10.5.1.7 Market Breakup by Country
10.5.1.8 Key Players
10.5.1.9 Market Forecast (2024-2032)
10.6 Attractive Investment Proposition by Region

11 Global Cell and Gene Therapy Market – Competitive Landscape
11.1 Overview
11.2 Market Structure
11.3 Market Share by Key Players
11.4 Market Player Positioning
11.5 Top Winning Strategies
11.6 Competitive Dashboard
11.7 Company Evaluation Quadrant

12 Profiles of Key Players
12.1 Amgen Inc.
12.1.1 Business Overview
12.1.2 Services Offered
12.1.3 Business Strategies
12.1.4 Financials
12.1.5 SWOT Analysis
12.1.6 Major News and Events
12.2 Biogen
12.2.1 Business Overview
12.2.2 Services Offered
12.2.3 Business Strategies
12.2.4 Financials
12.2.5 SWOT Analysis
12.2.6 Major News and Events
12.3 Bluebird bio, Inc.
12.3.1 Business Overview
12.3.2 Services Offered
12.3.3 Business Strategies
12.3.4 Financials
12.3.5 SWOT Analysis
12.3.6 Major News and Events
12.4 Bristol-Myers Squibb
12.4.1 Business Overview
12.4.2 Services Offered
12.4.3 Business Strategies
12.4.4 Financials
12.4.5 SWOT Analysis
12.4.6 Major News and Events
12.5 Gilead Science
12.5.1 Business Overview
12.5.2 Services Offered
12.5.3 Business Strategies
12.5.4 Financials
12.5.5 SWOT Analysis
12.5.6 Major News and Events
12.6 Kolon TissueGene Inc.
12.6.1 Business Overview
12.6.2 Services Offered
12.6.3 Business Strategies
12.6.4 Major News and Events
12.7 Orchard Therapeutics plc.
12.7.1 Business Overview
12.7.2 Services Offered
12.7.3 Business Strategies
12.7.4 Financials
12.7.5 Major News and Events
12.8 Pfizer Inc
12.8.1 Business Overview
12.8.2 Services Offered
12.8.3 Business Strategies
12.8.4 Financials
12.8.5 SWOT Analysis
12.8.6 Major News and Events
12.9 Renova Therapeutics
12.9.1 Business Overview
12.9.2 Services Offered
12.9.3 Business Strategies
12.9.4 Major News and Events
12.10 Spark Therapeutics, Inc.
12.10.1 Business Overview
12.10.2 Services Offered
12.10.3 Business Strategies
12.10.4 Major News and Events

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

13 Global Cell and Gene Therapy Market - Industry Analysis
13.1 Drivers, Restraints, and Opportunities
13.1.1   Overview
13.1.2   Drivers
13.1.3   Restraints
13.1.4   Opportunities
13.1.5   Impact Analysis
13.2 Porters Five Forces Analysis
13.2.1   Overview
13.2.2   Bargaining Power of Buyers
13.2.3   Bargaining Power of Suppliers
13.2.4   Degree of Competition
13.2.5   Threat of New Entrants
13.2.6   Threat of Substitutes
13.3 Value Chain Analysis

14 Strategic Recommendations

15 Appendix

Purchase Options New Year Sale

Inquire Before Buying

Speak to an Analyst

Request Brochure

Request Customization

Benefits of Customization

Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.